Français
ItalianoBond Amgen 2.125% ( US031162BQ24 ) in USD
| Issuer | Amgen | ||||||||
| Market price | 100.00 % ⇌ | ||||||||
| Country |  United States
|
||||||||
| ISIN code |
 US031162BQ24 ( in USD )
|
||||||||
| Interest rate | 2.125% per year ( payment 2 times a year) | ||||||||
| Maturity | 15/05/2017 - Bond has expired | ||||||||
|
Prospectus brochure in PDF format |
|||||||||
| Minimal amount | 2 000 USD | ||||||||
| Total amount | 1 250 000 000 USD | ||||||||
| Cusip | 031162BQ2 | ||||||||
| Standard & Poor's ( S&P ) rating | A ( Upper medium grade - Investment-grade ) | ||||||||
| Moody's rating | Baa1 ( Lower medium grade - Investment-grade ) | ||||||||
| Detailed description |
Amgen is a leading biotechnology company focused on developing and delivering innovative therapies for serious illnesses in areas such as oncology, cardiovascular disease, and inflammation. The Bond issued by Amgen ( United States ) , in USD, with the ISIN code US031162BQ24, pays a coupon of 2.125% per year. The coupons are paid 2 times per year and the Bond maturity is 15/05/2017 The Bond issued by Amgen ( United States ) , in USD, with the ISIN code US031162BQ24, was rated Baa1 ( Lower medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Amgen ( United States ) , in USD, with the ISIN code US031162BQ24, was rated A ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||
| |||||||||